ProBio and Kun Tuo Announce Strategic Collaboration to Deliver Integrated CDMO-CRO Solutions for Advanced Therapies

Summary

ProBio and Kun Tuo announced a strategic partnership combining CDMO and CRO capabilities to accelerate Investigator-Initiated Trials and clinical execution in China. The collaboration integrates manufacturing, development, and clinical operations expertise for advanced therapies.